GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Interest Income

Suzhou Highfine Biotech Co (SZSE:301393) Interest Income : ¥48.2 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Suzhou Highfine Biotech Co's interest income for the three months ended in Sep. 2024 was ¥4.4 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ¥48.2 Mil.

Suzhou Highfine Biotech Co Interest Income Historical Data

The historical data trend for Suzhou Highfine Biotech Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co Interest Income Chart

Suzhou Highfine Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Income
Get a 7-Day Free Trial 1.85 1.12 0.79 0.68 27.50

Suzhou Highfine Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 20.13 12.44 11.18 4.43

Suzhou Highfine Biotech Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥48.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Highfine Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Interest Income
Comparable Companies
SZSE:300158 SHSE:600351 SHSE:688566 SHSE:603207 SHSE:688073 SZSE:300111 SHSE:688621 SHSE:603676 SHSE:600829 SHSE:600479 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Website
https://www.highfine.com
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Executives
Dong Sheng Jun Directors, executives
Lu Xue Gen Directors, executives
Lv Min Jie Directors, executives
Xu Jie Directors, executives

Suzhou Highfine Biotech Co Headlines

No Headlines